
Dr. Durand develops and evaluates novel biotherapeutics via approved SOPs, product validation and cGMP compliant manufacturing operations. She is responsible for translating research processes and developing processes and techniques in support of all phases of cellular therapy product development. Nisha works closely with the Manufacturing, Quality Assurance and Quality Control teams to advance regenerative medicine to the clinical practice
Also Speaking
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023